Puerarin‑Loaded pH‑Responsive ZIF‑90 Nanoparticles Ameliorate Osteoporosis via Enhancing H3K18 Lactylation and Suppressing Aberrant Osteoclast Activation
Advanced Science · 27.09.2026
DOI: 10.1002/advs.77869 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 27.09.2026. Verfasst von Jiajia Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Trauma, School of Medicine, Shanghai Fourth People's Hospital, Tongji University, Shanghai, People's Republic of China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, "Medicine +X" interdisciplinary research program of Tongji University, Clinical Key Specialty Construction Project of Hongkou District Health Commission.
Abstract (Originalsprache)
Osteoporosis is characterized by dysregulated osteoclast activity, leading to excessive bone resorption and structural damage. In this study, we developed pH‐responsive ZIF‐90 nanoparticles loaded with puerarin (PU) (ZIF‐90@PU) for microenvironment‐responsive osteoporosis therapy through epigenetic modulation. Following self‐assembly, the nanoparticles underwent dynamic light scattering (DLS), field emission scanning electron microscopy (FE‐SEM), powder X‐ray diffraction (PXRD), Fourier‐transform infrared spectroscopy (FTIR), and X‐ray photoelectron spectroscopy (XPS); these analyses verified efficient puerarin encapsulation and pH‐triggered release. In cell‐based experiments, ZIF‐90@PU suppressed the differentiation of bone marrow‐derived macrophages (BMMs) into osteoclasts while promoting osteogenic differentiation of bone marrow‐derived mesenchymal stem cells (BMSCs). Administration of ZIF‐90@PU to ovariectomized (OVX) mice produced significant gains in bone mineral density, trabecular architecture, and bone strength without detectable toxicity. Mechanistically, ZIF‐90@PU treatment was associated with increased H3K18 lactylation and reduced NFATc1 signaling, accompanied by suppression of osteoclast activation. This study introduces ZIF‐90@PU as a novel epigenetic‐modulating nanomedicine for osteoporosis treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Trauma, School of Medicine, Shanghai Fourth People's Hospital, Tongji University, Shanghai, People's Republic of China.
- Department of Orthopedic Trauma, Haimen People's Hospital of Jiangsu Province, Haimen, People's Republic of China.
- Department of Orthopedic, Guangming Traditional Chinese Medicine Hospital of Pudong New Area, Shanghai, People's Republic of China.
ORCID-Profile: Jiajia Lu, Xiaojian Shi
Förderung
- National Natural Science Foundation of China
- "Medicine +X" interdisciplinary research program of Tongji University
- Clinical Key Specialty Construction Project of Hongkou District Health Commission
- Mandatory project of Nantong Health Commission
- Scientific Research Project of Jiangsu Geriatrics Society
Zitieren
APA
Lu, J., Xi, Y., Wang, S., Chen, Y., Yang, J., & Shi, X. (2026). Puerarin‑Loaded pH‑Responsive ZIF‑90 Nanoparticles Ameliorate Osteoporosis via Enhancing H3K18 Lactylation and Suppressing Aberrant Osteoclast Activation. Advanced Science. https://doi.org/10.1002/advs.77869
Vancouver
Lu J, Xi Y, Wang S, Chen Y, Yang J, Shi X. Puerarin‑Loaded pH‑Responsive ZIF‑90 Nanoparticles Ameliorate Osteoporosis via Enhancing H3K18 Lactylation and Suppressing Aberrant Osteoclast Activation. Advanced Science. 2026. doi:10.1002/advs.77869
BibTeX
@article{Lu2026,
author = {Lu, Jiajia and Xi, Yue and Wang, Sheng and Chen, Ye and Yang, Jiajie and Shi, Xiaojian},
title = {Puerarin‑Loaded pH‑Responsive ZIF‑90 Nanoparticles Ameliorate Osteoporosis via Enhancing H3K18 Lactylation and Suppressing Aberrant Osteoclast Activation},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.77869}
}
EUVIMED